Sentante

Sentante is a Lithuanian medical technology company focused on developing a robotic, teleoperated system for endovascular interventions, particularly in neurovascular and cardiovascular procedures. The company's mission is to enhance healthcare accessibility for patients and protect medical personnel from radiation exposure. The Sentante robotic system allows physicians to remotely manipulate up to three endovascular instruments, such as catheters and guidewires, simultaneously. This technology maintains the tactile feedback of manual operations while improving precision and procedural outcomes through advanced X-ray visualization. By enabling remote procedures, Sentante optimizes hospital workflows and reduces the need for patient transfers. The company has achieved significant milestones, including the first fully robotic remote endovascular stroke thrombectomy in an animal model and its initial use in human patients. Sentante has received accolades like the iF Design Award 2025 and secured €6 million in seed funding to support clinical trials and international market launch. Its primary customers include hospitals and healthcare institutions looking to modernize their catheterization labs with robotic technologies.

• Employees 24
• Founded 2017
• Total Funding $6574320